16 November 2026 – Community groups have welcomed new national advice supporting the use of puberty blockers for trans young people, saying it reinforces the importance of ensuring young people can access clinically appropriate care wherever they live in Australia.
The federal government announced the review by the National Health and Medical Research Council (NHMRC) in January 2025, with advice on puberty blockers released on Monday.
It recommends puberty suppressants as a treatment option for young people who have commenced puberty, have gender incongruence and are assessed as suitable, with decisions made jointly by the young person, their parents and their clinicians.
The advice from Australia’s peak medical research body also found that published data indicates only a small number of young Australians are accessing this care, and that withholding care to ‘wait and see’ as puberty progresses “can affect the young person’s physical and mental health, wellbeing, and ability to function”.
Equality Australia CEO Anna Brown:
“This advice reinforces that the care trans young people are receiving in Australia today is grounded in evidence, informed by clinical expertise and guided by the individual needs of young people.